关于治疗动脉硬性的最新情况
1Arterial Hypertension, Metabolic Unit, University Hospital, Fundacion Favaloro, Buenos Aires, Argentina.
Current hypertension reviews
|November 15, 2025
概括
生活方式的改变和药物治疗是控制动脉硬的关键,这种情况与心血管衰老有关. 这种方法提高了动脉弹性,并减少了整体心血管风险,从而改善健康.
科学领域:
- 心血管医学 心血管医学
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉硬是心血管衰老的主要指标,意味着动脉弹性降低和心血管风险增加.
- 有效的管理需要解决根本原因和减轻相关风险,而不仅仅是症状控制.
研究的目的:
- 阐明生活方式的修改,以治疗动脉硬.
- 审查针对动脉硬性和相关心血管风险的药理干预措施.
主要方法:
- 关于生活方式干预的文献综述,包括饮食,运动和戒烟.
- 对药理疗法的分析,包括抗高血压药,抗糖尿病药和他类药.
- 探索新兴疗法和持续监测的重要性.
主要成果:
- 改变生活方式,如有氧运动,健康饮食和戒烟,可以改善动脉功能,降低心血管风险.
- 药物,如氨酸- ангиотензин- алдостерон系统抑制剂,通道阻断剂,SGLT2抑制剂,GLP-1受体激动剂和他类药物,对动脉硬有明显的益处.
- 这些治疗方法共同有助于改善血压控制,动脉顺应和整体心血管健康.
结论:
- 治疗动脉硬需要一个综合策略,包括生活方式调整,药物治疗和新疗法.
- 持续监测和整体方法对于增强动脉弹性和改善生活质量至关重要.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
231
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
231
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
447
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
447
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
542
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
542
Aortic Regurgitation III: Medical Management
383
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
383
Hypertension IV: Drug Therapy and Lifestyle Modifications
600
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
600


